Wired Business Spoken Edition
US Government Awards Moderna $176 Million for mRNA Bird Flu Vaccine
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:06:40
- Mas informaciones
Informações:
Sinopsis
As fears of a pandemic mount, the biotech company’s mRNA vaccine trial is set to release Phase 1/2 results later this year, with a larger Phase 3 trial expected to begin in 2025. Learn about your ad choices: dovetail.prx.org/ad-choices
